00:59 , Jan 18, 2019 |  BC Week In Review  |  Company News

Bioharmony, Boehringer partner to develop antimicrobials

Antimicrobial company Bioharmony Therapeutics Inc. (New York, N.Y.) partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to develop bacteriophage lysins to treat systemic multidrug-resistant Acinetobacter infections. Bioharmony declined to disclose financial terms and details regarding the...
21:58 , Jan 15, 2019 |  BC Extra  |  Company News

Bioharmony, Boehringer partner to develop antimicrobials

Antimicrobial company Bioharmony Therapeutics Inc. (New York, N.Y.) partnered with Boehringer Ingelheim GmbH (Ingelheim, Germany) to develop bacteriophage lysins to treat systemic multidrug-resistant Acinetobacter infections. Bioharmony declined to disclose financial terms and details regarding the...